首页> 外文期刊>Molecular Biology and Evolution >Novel Venom Proteins Produced by Differential Domain-Expression Strategies in Beaded Lizards and Gila Monsters (genus Heloderma)
【24h】

Novel Venom Proteins Produced by Differential Domain-Expression Strategies in Beaded Lizards and Gila Monsters (genus Heloderma)

机译:珠链蜥蜴和吉拉怪物(Heloderma属)中的差异域表达策略产生的新型毒蛋白。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The origin and evolution of venom proteins in helodermatid lizards were investigated by multidisciplinary techniques. Our analyses elucidated novel toxin types resultant from three unique domain-expression processes: 1) The first full-length sequences of lethal toxin isoforms (helofensins) revealed this toxin type to be constructed by an ancestral monodomain, monoproduct gene (beta-defensin) that underwent three tandem domain duplications to encode a tetradomain, monoproduct with a possible novel protein fold; 2) an ancestral monodomain gene (encoding a natriuretic peptide) was medially extended to become a pentadomain, pentaproduct through the additional encoding of four tandemly repeated proline-rich peptides (helokinestatins), with the five discrete peptides liberated from each other by posttranslational proteolysis; and 3) an ancestral multidomain, multiproduct gene belonging to the vasoactive intestinal peptide (VIP)/glucagon family being mutated to encode for a monodomain, monoproduct (exendins) followed by duplication and diversification into two variant classes (exendins 1 and 2 and exendins 3 and 4). Bioactivity characterization of exendin and helokinestatin elucidated variable cardioactivity between isoforms within each class. These results highlight the importance of utilizing evolutionary-based search strategies for biodiscovery and the virtually unexplored potential of lizard venoms in drug design and discovery.
机译:通过多学科技术研究了蛇毒蜥蜴中毒蛋白的起源和进化。我们的分析阐明了由三种独特的结构域表达过程产生的新型毒素类型:1)致死性毒素同工型(helofensins)的第一个全长序列显示这种毒素类型由祖先的单结构域,单产物基因(β-防御素)构建,进行了三个串联结构域重复,以编码具有可能的新蛋白折叠的四结构域单产物; 2)通过额外编码四个串联重复的富含脯氨酸的肽(Helokinestatins),将祖先单结构域基因(编码利钠肽)中间延伸成为五结构域,五产物,通过翻译后蛋白水解使五个离散的肽彼此释放; 3)将属于血管活性肠肽(VIP)/胰高血糖素家族的祖先多结构域多产物基因突变,以编码单结构域单产物(延伸蛋白),然后复制和多样化为两个变异类(延伸蛋白1和2和延伸蛋白3)和4)。 exendin和helokinestatin的生物活性表征阐明了每一类同工型之间的可变心脏活性。这些结果突出了利用基于进化的搜索策略进行生物发现的重要性以及蜥蜴毒液在药物设计和发现中几乎未开发的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号